HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS Read more about HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS South Korea2020-7026443Filed on 2020-09-14
NOVOBIOCIN ANALOGUES HAVING MODIFIED SUGAR MOIETIES Read more about NOVOBIOCIN ANALOGUES HAVING MODIFIED SUGAR MOIETIES United Kingdom10744355.8Filed on 2010-02-19
NOVOBIOCIN ANALOGUES HAVING MODIFIED SUGAR MOIETIES Read more about NOVOBIOCIN ANALOGUES HAVING MODIFIED SUGAR MOIETIES France10744355.8Filed on 2010-02-19
NOVOBIOCIN ANALOGUES HAVING MODIFIED SUGAR MOIETIES Read more about NOVOBIOCIN ANALOGUES HAVING MODIFIED SUGAR MOIETIES Germany10744355.8Filed on 2010-02-19
NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS Read more about NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS United Kingdom05824355.1Filed on 2005-11-03
NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS Read more about NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS France05824355.1Filed on 2005-11-03
NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS Read more about NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS Germany05824355.1Filed on 2005-11-03
High ASS1 Expressing Tumors Embody A Purine Rich Genomic Signature And Sensitivity To Purine Depletion Read more about High ASS1 Expressing Tumors Embody A Purine Rich Genomic Signature And Sensitivity To Purine Depletion Patent Cooperation TreatyPCT/IL2020/050708Filed on 2020-06-24
Chimeric Antigen Receptors Targeting CD-19 Read more about Chimeric Antigen Receptors Targeting CD-19 Australia2020267211Filed on 2020-11-11
17-BETA-HYDROXYWITHANOLIDES AND USE THEREOF IN TREATING CANCER Read more about 17-BETA-HYDROXYWITHANOLIDES AND USE THEREOF IN TREATING CANCER US Application 16/978,442Filed on 2020-09-04